Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma

被引:0
作者
Grant L. Lin
Surya Nagaraja
Mariella G. Filbin
Mario L. Suvà
Hannes Vogel
Michelle Monje
机构
[1] Stanford University,Department of Neurology
[2] Dana-Farber/Boston Children’s Cancer and Blood Disorder Center and Harvard Medical School,Department of Pediatric Oncology
[3] Massachusetts General Hospital,Department of Pathology
[4] Broad Institute of Harvard and Massachussetts Institute of Technology (MIT),Klarman Cell Observatory
[5] Stanford University,Department of Pathology
[6] Stanford University,Department of Pediatrics
来源
Acta Neuropathologica Communications | / 6卷
关键词
Diffuse intrinsic pontine glioma; Tumor-associated macrophage; Tumor-infiltrating lymphocyte; Glioma; Glioblastoma; Immune microenvironment;
D O I
暂无
中图分类号
学科分类号
摘要
Diffuse intrinsic pontine glioma (DIPG) is a universally fatal malignancy of the childhood central nervous system, with a median overall survival of 9–11 months. We have previously shown that primary DIPG tissue contains numerous tumor-associated macrophages, and substantial work has demonstrated a significant pathological role for adult glioma-associated macrophages. However, work over the past decade has highlighted many molecular and genomic differences between pediatric and adult high-grade gliomas. Thus, we directly compared inflammatory characteristics of DIPG and adult glioblastoma (GBM). We found that the leukocyte (CD45+) compartment in primary DIPG tissue samples is predominantly composed of CD11b + macrophages, with very few CD3+ T-lymphocytes. In contrast, T-lymphocytes are more abundant in adult GBM tissue samples. RNA sequencing of macrophages isolated from primary tumor samples revealed that DIPG- and adult GBM-associated macrophages both express gene programs related to ECM remodeling and angiogenesis, but DIPG-associated macrophages express substantially fewer inflammatory factors than their adult GBM counterparts. Examining the secretome of glioma cells, we found that patient-derived DIPG cell cultures secrete markedly fewer cytokines and chemokines than patient-derived adult GBM cultures. Concordantly, bulk and single-cell RNA sequencing data indicates low to absent expression of chemokines and cytokines in DIPG. Together, these observations suggest that the inflammatory milieu of the DIPG tumor microenvironment is fundamentally different than adult GBM. The low intrinsic inflammatory signature of DIPG cells may contribute to the lack of lymphocytes and non-inflammatory phenotype of DIPG-associated microglia/macrophages. Understanding the glioma subtype-specific inflammatory milieu may inform the design and application of immunotherapy-based treatments.
引用
收藏
相关论文
共 202 条
[1]  
Aguzzi A(2013)Microglia: scapegoat, saboteur, or something else? Science 339 156-161
[2]  
Barres BA(2014)Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating Nat Genet 46 451-456
[3]  
Bennett ML(2016)Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an ivy Foundation early phase clinical trials consortium phase II study Neuro-Oncology 18 557-564
[4]  
Buczkowicz P(2013)Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children Childs Nerv Syst 29 1313-1319
[5]  
Hoeman C(2017)Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy J Immunotherapy Cancer 5 897-909
[6]  
Rakopoulos P(2014)Human pontine glioma cells can induce murine tumors Acta Neuropathol 127 1279-1280
[7]  
Pajovic S(2017)Contemporary survival endpoints: an international diffuse intrinsic pontine glioma registry study Neuro-Oncology 19 331-335
[8]  
Letourneau L(2018)Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq Science 360 462-466
[9]  
Butowski N(2014)Recurrent somatic mutations in Nat Genet 46 435-437
[10]  
Colman H(2015)High frequency of H3F3A (K27M) mutations characterizes pediatric and adult high-grade gliomas of the spinal cord Acta Neuropathol 130 498-518